“…The concentrations of sHLA‐I, sHLA‐I‐HC, sHLA‐II, and sFasL molecules were determined by double‐determinant immunoassay (DDIA), as described, 20,38,47,48 with minor modifications. W6/32, TP 25.99, LGII‐612.14, and NOK‐2 MoAbs and biotinylated NAMB‐1, HC‐10, Q5/13, and NOK1 MoAbs were utilized to capture and detect sHLA‐I, sHLA‐I‐HC, sHLA‐II, and sFasL molecules, respectively.…”